The Cancer Chronicles: how little we fully understand

The Cancer Chronicles: Unlocking Medicine's Deepest Mystery is George Johnson's account of cancer as a biological and scientific puzzle. He wrote it after his wife was diagnosed with leiomyosarcoma. The book describes it as a rare and aggressive cancer of smooth muscle tissue. Knopf published the book in 2013.

Johnson is a longtime science journalist, not a physician or scientist. The book reflects that background. It is reported and pulled together from a wide range of research and interviews. It is not written from clinical work. His wife's illness runs through the book as a personal thread. But the book is not built as a memoir of her treatment. Her illness is more the occasion for the book's real subject. That subject is cancer's underlying biology, and the real limits of what science now knows.

The book resists tidy narratives. Some popular science writing about cancer moves toward a single unifying explanation. Some tells a clear story of progress. Johnson keeps returning instead to what remains uncertain. Why do cancer rates vary as they do? How much of cancer risk can be traced to known causes, and how much to effectively random errors in cells? And how hard is it to draw firm conclusions from patterns in population data?

The book leans into scientific uncertainty rather than resolving it. So this page is careful to draw a line. Some claims the book makes are well supported by current federal sources. Elsewhere the book is honestly describing an open scientific question, not a settled answer.

The book shifts in tone and moves back and forth in time. It does not follow one time line. Chapters combine two kinds of material. One is Johnson's account of his wife's diagnosis and treatment. The other is reporting on where cancer came from in evolution. He covers its presence across the animal kingdom. He also reports on modern research into the genes and cell biology behind tumors.

A recurring theme is cancer's deep evolutionary age. The book discusses evidence that cancer-like growths have existed in multicellular organisms for hundreds of millions of years. That framing casts cancer less as a modern disease of industrial civilization. It looks more like a built-in risk of being made of dividing cells at all. Even so, the book also takes up modern, environmental causes that add to cancer risk.

Other sections take on popular claims about cancer causes and prevention. Johnson looks at them directly, and with doubt. He examines how studies of populations work. He explains why a link found in one study rarely proves cause. Some claims name a specific food or exposure as a cancer cure or cause. He shows how often those claims outrun the evidence behind them. The book does not offer a symptom-by-symptom or treatment-by-treatment guide. Its chapters are organized around ideas and questions, not around a patient's practical decisions.

The book is strongest on what science does not yet know. It treats that as an honest subject in its own right, not something to paper over. Cancer research turns up a huge number of findings that show links. Many are later reversed, or made more complex by later work. Johnson's roots as a science journalist show in how carefully he handles this. He is clear about what a given study can and cannot establish.

The book is also unusually clear-eyed about research attention. Rare and common cancers do not get the same amount of it. His wife's leiomyosarcoma is rare enough to lack a large research literature. More common cancers have built up far more trial and population data. Breast and colon cancer are two such cases. The book uses that gap directly. It shows how uneven cancer research funding and attention are across cancer types.

The book pushes back on both ends of the spectrum. It challenges overstated alternative-medicine claims. At points it also challenges overly tidy mainstream stories of steady scientific progress. That willingness gives it a credibility more one-sided books in this category lack.

The book is also strong on the evolutionary framing of cancer. That angle is less common in popular cancer writing than the historical or clinical framings other books take. Johnson presents cancer as a near-inevitable byproduct of multicellular life. It has likely affected animals for as long as animals have existed. That pulls the disease away from a purely modern, industrial-age story. It moves it closer to a basic risk of biology. Many readers hear about cancer mainly in terms of specific modern exposures. For them, that is a fresh and useful lens.

The book's skepticism toward simple explanations is a genuine strength. But it can also leave a reader without a clear picture of what is established and what is really uncertain. That is especially true for a reader looking for practical guidance about their own risk or diagnosis. Such a reader may want less of a meditation on how scientific knowledge is made.

The book came out in 2013. Cancer genomics in particular has moved on a great deal since then. Sequencing costs have fallen. Tumor genomic profiling is now far more routine in the clinic. That has changed how one patient's cancer is described and treated. The book was written at an earlier stage of that shift. It could not fully foresee it.

The book's personal thread involves his wife's specific case. It is, rightly, her story as told through Johnson's account. The book is not a guide to leiomyosarcoma, or to any other rare cancer's current treatment. A reader with that diagnosis, or another rare cancer, should treat the personal material as one family's experience. It is not clinical information about the disease itself.

One more thing is worth noting. The book covers a wide range of early findings. Some have since been overtaken. So it is bound to hold some claims that later work has revised or overturned. That is an ordinary feature of any science book on a field still in motion. It is not a special flaw of this one. A reader may want to lean on a specific research claim from the book. For a current decision, it is better to check that claim against a current source.

Johnson makes a core scientific claim. Cancer comes from a build-up of genetic changes in cells. It does not come from any single outside cause. That matches NCI's own current account closely. It is worth stating that account directly.

NCI describes cancer as a genetic disease. It is caused by changes to genes that control how cells grow, divide, and die. NCI identifies three categories of genes at the center of this. Proto-oncogenes can become cancer-driving oncogenes when they mutate. Tumor suppressor genes normally hold cell division in check, and losing them removes that check. DNA repair genes, when they fail, let other mutations build up unchecked. Per NCI, the genetic changes behind cancer can arise in several ways. Some are errors during ordinary cell division. Some come from environmental damage, such as chemicals in tobacco smoke or ultraviolet light. Others are mutations inherited from a parent.

NCI also identifies specific, well-established cancer-causing substances. It notes that the National Toxicology Program's Report on Carcinogens names known human carcinogens based on built-up evidence. NCI lists examples including asbestos, benzene, formaldehyde, radon, secondhand tobacco smoke, arsenic, and vinyl chloride. But NCI is clear about a limit here. Naming something a carcinogen does not mean that every person exposed to it will get cancer. The outcome depends on how much exposure there was, and for how long. It also depends on a person's own genes. The book spends real effort explaining that point to a general reader.

This is where the book's resistance to single-cause explanations is really well supported. NCI's own framing is that cancer comes from genetic changes that can arise from cell division errors, environmental damage, or inheritance. NCI also says it is usually not possible to know exactly why one person develops cancer and another does not.

Two further points here are worth a look. One is how known risk factors are set. The other is what they mean for one person. See family history and cancer risk. See also cancer prevention overview and occupational carcinogens.

It suits a reader who wants to understand cancer biology in real depth. That includes its open questions. Such a reader has to be at ease with a book that offers no clean, reassuring ending. It suits someone keen to see how research on cancer genes and populations really works. The book is skeptical about overstated claims. That makes it a useful corrective. Many readers have met claims about cancer causes or cures that sound sure but are unproven. The book is a fair companion to more clinical reading. Its main value is in building a better sense of what a given cancer claim is worth. That holds whether the claim comes from the news or from a well-meaning friend.

It is less suited to a reader who wants a straightforward, practical guide. The book's interests lie in the underlying science and its uncertainties, not in clinical guidance. A recently diagnosed reader looking for concrete next steps may find it hard going at first. The tone is honest, but it is likely more useful later. By then the immediate practical questions of diagnosis and treatment are already in the hands of a care team.

Cancer Explained runs free of charge and free of ads; donations are what keep it that way, if you're able.

• NCI — What Is Cancer?
• NCI — Cancer-Causing Substances in the Environment
• NCI — Risk Factors for Cancer
• family history and cancer risk (Cancer Explained)

This page discusses The Cancer Chronicles for education. It is not medical advice, and nothing here is a judgement of anyone's real medical care.